Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr326.70 DKK
Change Today -1.80 / -0.55%
Volume 909.6K
NZYMB On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Copenhagen
Frankfurt
As of 11:04 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Per Falholt

Executive Vice President of Research & Development, Novozymes A/S
AgeTotal Calculated CompensationThis person is connected to 13 board members in 3 different organizations across 3 different industries.

See Board Relationships
56kr11,600,000
As of Fiscal Year 2014

Background*

Mr. Per Falholt serves as the Executive Vice President of Research and Development at Novozymes A/S. Mr. Falholt joined Novozymes in 1984 as a Research Chemist in the Enzyme pilot plant and served as its Chief Scientific Officer. Mr. Falholt was appointed as a Manager of the Detergent Enzyme Division in 1987 and as a Director responsible for the application and development of new products for the detergent industry in 1990. He joined the Enzyme Development and Applications ...

Read Full Background

Corporate Headquarters*

Krogshoejvej 36
Bagsvaerd, -- 2880

Denmark

Phone: 45 44 46 00 00
Fax: 45 44 46 99 99

Board Members Memberships*

Director
Director

Education*

MS 1983
Technical University of Denmark

Other Affiliations*

Annual Compensation*

Salarykr4,400,000
Bonuskr1,600,000
Total Annual Compensationkr6,000,000

Stock Options*

Long Term Incentive Plankr4,200,000
All Other Compensationkr1,400,000
Total Number of Options219,913

Total Compensation*

Total Annual Cash Compensationkr7,400,000
Total Short Term Compensationkr6,000,000
Other Long Term Compensationkr1,400,000
Total Calculated Compensationkr11,600,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr326.70 DKK -1.80

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul Manning Chief Executive Officer, President, Director, Member of Executive Committee, Member of Finance Committee and Member of Scientific Advisory Committee
Sensient Technologies Corporation
$800.0K
Stan McCarthy Chief Executive Officer and Executive Director
Kerry Group plc
€1.5M
Magdalena Martullo-Blocher Vice-Chairman and Chief Executive Officer
EMS-Chemie Holding AG
--
Antonio Hernández Callejas Chairman, Chief Executive Officer, Chairman of Executive Committee and Member of Strategy & Investment Committee
Ebro Foods SA
€2.7M
Cees de Jong M.D., MBAChief Executive Officer, President and Member of Executive Board
Chr. Hansen Holding A/S
€890.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.